Clinical Research Directory
Browse clinical research sites, groups, and studies.
ACRODAT Prospective Evaluation Study
Sponsor: University of Aarhus
Summary
ACRODAT® is a new software medical device developed by a group of acromegaly experts to help practising endocrinologists assess disease activity in patients with acromegaly. It uses 5 key parameters (IGF-I level, tumour status, comorbidities, symptoms and Quality of life) to evaluate the patient's health status. The purpose of this post marketing surveillance study is to prospectively evaluate whether patients monitored by ACRODAT® with appropriate clinical decisions based on disease activity status will benefit from improved treatment outcomes both in the short and in the long term.
Official title: Post-marketing Surveillance Study to Evaluate the Clinical Utility of ACRODAT in an International, Randomised, Non-interventional Study
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2020-01-15
Completion Date
2025-03-24
Last Updated
2026-06-11
Healthy Volunteers
No
Conditions
Interventions
Acrodat software
Acrodat is a newly developed software medical device to access disease activity in acromegaly based on five parameters: IGF-I, tumour size, comorbidities, symptoms and quality of life.
Locations (1)
Århus University Hospital
Aarhus, Århus, Denmark